Axoft announced promising preliminary results from the first-in-human study of its implantable brain-computer interface (iBCI) technology using Fleuron, a breakthrough ultrasoft material. The Cambridge, Massachusetts-based
Orchestra BioMed (Nasdaq: OBIO) announced it received FDA breakthrough device designation for its atrioventricular interval modulation (AVIM) therapy, delivered via an implantable pacemaker system. AVIM
MARRS study milestone positions Perfuze for U.S. expansion Perfuze has completed enrollment in its MARRS trial, evaluating the Millipede 088 aspiration catheter for large vessel
Expanded lateral access solutions for thoracolumbar pathologies Alphatec Holdings (ATEC) has launched its new Prone TransPsoas (PTP) Corpectomy system, enabling advanced deformity and corpectomy procedures
Optune Lua offers new hope for metastatic NSCLC patients Novocure has received CE mark approval for Optune Lua, its wearable device designed to treat metastatic
Stay ahead in MedTech with industry updates, breakthroughs, and expert
insights—delivered straight to your inbox.
© 2025 MEDWIRE.AI. All rights reserved. MEDWIRE.AI is a trusted source for MedTech news and insights. Our website content and services are for informational purposes only. MEDWIRE.AI does not provide medical advice, diagnosis, or treatment.
